BP1001-A in Patients With Advanced or Recurrent Solid Tumors

NCT04196257 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult
Carcinoma, Ovarian Epithelial
Fallopian Tube Neoplasms
Endometrial Cancer
Peritoneal Cancer
Solid Tumor

Interventions

DRUG: BP1001-A (Liposomal Grb2 Antisense Oligonucleotide)
DRUG: BP1001-A (Liposomal Grb2 Antisense Oligonucleotide) with paclitaxel

Sponsor

Bio-Path Holdings, Inc.